Abstract:Background: : MR-Egger regression has recently been proposed as a method for Mendelian randomization (MR) analyses incorporating summary data estimates of causal effect from multiple individual variants, which is robust to invalid instruments. It can be used to test for directional pleiotropy and provides an estimate of the causal effect adjusted for its presence. MR-Egger regression provides a useful additional sensitivity analysis to the standard inverse variance weighted (IVW) approach that assumes all variants are valid instruments. Both methods use weights that consider the single nucleotide polymorphism (SNP)-exposure associations to be known, rather than estimated. We call this the `NO Measurement Error' (NOME) assumption. Causal effect estimates from the IVW approach exhibit weak instrument bias whenever the genetic variants utilized violate the NOME assumption, which can be reliably measured using the F-statistic. The effect of NOME violation on MR-Egger regression has yet to be studied.Methods: An adaptation of the I2 statistic from the field of meta-analysis is proposed to quantify the strength of NOME violation for MR-Egger. It lies between 0 and 1, and indicates the expected relative bias (or dilution) of the MR-Egger causal estimate in the two-sample MR context. We call it IGX2 . The method of simulation extrapolation is also explored to counteract the dilution. Their joint utility is evaluated using simulated data and applied to a real MR example.Results: In simulated two-sample MR analyses we show that, when a causal effect exists, the MR-Egger estimate of causal effect is biased towards the null when NOME is violated, and the stronger the violation (as indicated by lower values of IGX2 ), the stronger the dilution. When additionally all genetic variants are valid instruments, the type I error rate of the MR-Egger test for pleiotropy is inflated and the causal effect underestimated. Simulation extrapolation is shown to substantially mitigate these adverse effects. We demonstrate our proposed approach for a two-sample summary data MR analysis to estimate the causal effect of low-density lipoprotein on heart disease risk. A high value of IGX2 close to 1 indicates that dilution does not materially affect the standard MR-Egger analyses for these data.Conclusions: : Care must be taken to assess the NOME assumption via the IGX2 statistic before implementing standard MR-Egger regression in the two-sample summary data context. If IGX2 is sufficiently low (less than 90%), inferences from the method should be interpreted with caution and adjustment methods considered.

Reclaiming mendelian randomization from the deluge of papers and misleading findings

Addressing the credibility crisis in Mendelian randomization

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

Use of Mendelian randomization to assess the causal status of modifiable exposures for rheumatic diseases

Selecting instruments for Mendelian randomization in the wake of genome-wide association studies

Non-linear mendelian randomization: detection of biases using negative controls with a focus on BMI, Vitamin D and LDL cholesterol

Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study

Reporting methodological issues of the mendelian randomization studies in health and medical research: a systematic review

STROBE-MR: Guidelines for strengthening the reporting of Mendelian randomization studies

Mendel’s laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issues

Mendelian Randomization: Concepts and Scope

Using Mendelian Randomization As the Cornerstone for Causal Inference in Epidemiology.

Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles

Interpreting findings from Mendelian randomization using the MR-Egger method

A Guide to Understanding Mendelian Randomization Studies

Managing the exponential growth of mendelian randomization studies

Selecting invalid instruments to improve Mendelian randomization with two-sample summary data

Mendelian randomization in cardiometabolic disease: challenges in evaluating causality

Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic

An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings